Global Ovulation Inducing Drug Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Clomiphene and Gonadotropins), By Route of Administration (Oral, Injectable, and Subcutaneous Methods), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Jan 2025
REPORT ID SI7784
PAGES 220
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Drug Class
      2. Market Attractiveness Analysis By Route of Administration
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising infertility rates
    3. Restraints
      1. High treatment costs
    4. Opportunities
      1.  Personalized medicine
    5. Challenges
      1. Regulatory approvals
  6. Global Ovulation Inducing Drug Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2. Clomiphene
    3. Gonadotropins
  7. Global Ovulation Inducing Drug Market Analysis and Projection, By Route of Administration
    1. Segment Overview
    2. Oral
    3. Injectable
    4. Subcutaneous Methods
  8. Global Ovulation Inducing Drug Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Ovulation Inducing Drug Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Ovulation Inducing Drug Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Merck and Co
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Mylan 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Bristol-Myers Squibb 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Amgen 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Watson Pharmaceuticals 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Eli Lilly
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Hikma Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Teva Pharmaceutical Industrie
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  AbbVie
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Teva Pharmaceutical Industrie 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Cardinal Health
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Aurobindo Pharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  2. Global Clomiphene, Ovulation Inducing Drug Market, By Region, 2023-2033(USD Billion)
  3. Global Gonadotropins, Ovulation Inducing Drug Market, By Region, 2023-2033(USD Billion)
  4. Global Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  5. Global Oral, Ovulation Inducing Drug Market, By Region, 2023-2033(USD Billion)
  6. Global Injectable, Ovulation Inducing Drug Market, By Region, 2023-2033(USD Billion)
  7. Global Subcutaneous Methods, Ovulation Inducing Drug Market, By Region, 2023-2033(USD Billion)
  8. North America Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  9. North America Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  10. U.S.  Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  11. U.S.  Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  12. Canada Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  13. Canada Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  14. Mexico Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  15. Mexico Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  16. Europe Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  17. Europe Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  18. Germany Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  19. Germany Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  20. France Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  21. France Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  22. U.K.  Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  23. U.K.  Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  24. Italy Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  25. Italy Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  26. Spain Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  27. Spain Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  28. Asia Pacific Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  29. Asia Pacific Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  30. Japan Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  31. Japan Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  32. China Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  33. China Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  34. India Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  35. India Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  36. South America Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  37. South America Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  38. Brazil Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  39. Brazil Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  40. The Middle East and Africa Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD   Billion)
  41. The Middle East and Africa Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD   Billion)
  42. UAE Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  43. UAE Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)
  44. South Africa Ovulation Inducing Drug Market, By Drug Class, 2023-2033(USD Billion)
  45. South Africa Ovulation Inducing Drug Market, By Route of Administration, 2023-2033(USD Billion)

 

List of Figures 

  1. Global Ovulation Inducing Drug Market Segmentation
  2. Ovulation Inducing Drug Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Ovulation Inducing Drug Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Ovulation Inducing Drug Market
  20. Ovulation Inducing Drug Market Segmentation, By Drug Class
  21. Ovulation Inducing Drug Market For Clomiphene, By Region, 2023-2033 ($ Billion)
  22.  Ovulation Inducing Drug Market For Gonadotropins, By Region, 2023-2033 ($ Billion)
  23.  Ovulation Inducing Drug Market Segmentation, By Route of Administration
  24.  Ovulation Inducing Drug Market For Oral, By Region, 2023-2033 ($ Billion)
  25.  Ovulation Inducing Drug Market For Injectable, By Region, 2023-2033 ($ Billion)
  26. Ovulation Inducing Drug Market For Subcutaneous Methods, By Region, 2023-2033 ($ Billion)
  27. Merck and Co: Net Sales, 2023-2033 ($ Billion)
  28. Merck and Co: Revenue Share, By Segment, 2023 (%)
  29. Merck and Co: Revenue Share, By Region, 2023 (%)
  30. Mylan: Net Sales, 2023-2033 ($ Billion)
  31. Mylan: Revenue Share, By Segment, 2023 (%)
  32. Mylan: Revenue Share, By Region, 2023 (%)
  33. Bristol-Myers Squibb: Net Sales, 2023-2033 ($ Billion)
  34. Bristol-Myers Squibb: Revenue Share, By Segment, 2023 (%)
  35. Bristol-Myers Squibb: Revenue Share, By Region, 2023 (%)
  36. Amgen: Net Sales, 2023-2033 ($ Billion)
  37. Amgen: Revenue Share, By Segment, 2023 (%)
  38. Amgen: Revenue Share, By Region, 2023 (%)
  39. Watson Pharmaceuticals: Net Sales, 2023-2033 ($ Billion)
  40. Watson Pharmaceuticals: Revenue Share, By Segment, 2023 (%)
  41. Watson Pharmaceuticals: Revenue Share, By Region, 2023 (%)
  42. Eli Lilly: Net Sales, 2023-2033 ($ Billion)
  43. Eli Lilly: Revenue Share, By Segment, 2023 (%)
  44. Eli Lilly: Revenue Share, By Region, 2023 (%)
  45. Hikma Pharmaceuticals: Net Sales, 2023-2033 ($ Billion)
  46. Hikma Pharmaceuticals: Revenue Share, By Segment, 2023 (%)
  47. Hikma Pharmaceuticals: Revenue Share, By Region, 2023 (%)
  48. Teva Pharmaceutical Industrie: Net Sales, 2023-2033 ($ Billion)
  49. Teva Pharmaceutical Industrie: Revenue Share, By Segment, 2023 (%)
  50. Teva Pharmaceutical Industrie: Revenue Share, By Region, 2023 (%)
  51. AbbVie.: Net Sales, 2023-2033 ($ Billion)
  52. AbbVie.: Revenue Share, By Segment, 2023 (%)
  53. AbbVie.: Revenue Share, By Region, 2023 (%)
  54. Teva Pharmaceutical Industrie: Net Sales, 2023-2033 ($ Billion)
  55. Teva Pharmaceutical Industrie: Revenue Share, By Segment, 2023 (%)
  56. Teva Pharmaceutical Industrie: Revenue Share, By Region, 2023 (%)
  57. Cardinal Health: Net Sales, 2023-2033 ($ Billion)
  58. Cardinal Health: Revenue Share, By Segment, 2023 (%)
  59. Cardinal Health: Revenue Share, By Region, 2023 (%)
  60. Aurobindo Pharma: Net Sales, 2023-2033 ($ Billion)
  61. Aurobindo Pharma: Revenue Share, By Segment, 2023 (%)
  62. Aurobindo Pharma: Revenue Share, By Region, 2023 (%)
  63. Others: Net Sales, 2023-2033 ($ Billion)
  64. Others: Revenue Share, By Segment, 2023 (%)
  65. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:103
Pages:220
Countries covered:17
Companies covered::19
Forecast CAGR:CAGR of 5.35%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies